| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/05/2001 | WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | WO2001048162A2 Method for the production of vitamin a |
| 07/05/2001 | WO2001048161A2 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | WO2001048154A1 Maturation-promoting agent for immature dendritic cells |
| 07/05/2001 | WO2001048153A1 Reconstructing organs from decellularized biomaterial scaffold |
| 07/05/2001 | WO2001048152A1 Tissue engineering using mandibular cells |
| 07/05/2001 | WO2001048151A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048150A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048149A1 Adult bone marrow-origin cell capable of differentiating into heart muscle cell |
| 07/05/2001 | WO2001048148A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 07/05/2001 | WO2001048147A1 Cell culture medium containing growth factors and l-glutamine |
| 07/05/2001 | WO2001048145A2 High affinity tcr proteins and methods |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047961A1 P. gingivalis antigenic composition |
| 07/05/2001 | WO2001047959A2 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047952A2 Insecticidal proteins from bacillus thuringiensis |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047574A1 Methods and compositions for producing a fascial sling |
| 07/05/2001 | WO2001047354A1 Model animal with favorite onset of rheumatoid arthritis |
| 07/05/2001 | WO2001040446A8 Pour-on formulations |
| 07/05/2001 | WO2001021640A9 Identification and functional characterization of a new subfamily of sulfatases |
| 07/05/2001 | WO2001012777A3 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 07/05/2001 | WO2001011052A3 Monocellular or multicellular organisms for the production of riboflavin |
| 07/05/2001 | WO2001011018A3 Avian blastodermal cell lines |
| 07/05/2001 | WO2001004334A3 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 07/05/2001 | WO2001002592A3 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 07/05/2001 | WO2001002563A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001002019A3 Control of gene expression |
| 07/05/2001 | WO2001002005A3 Treatment of dentritic cells for induction of immune tolerance |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 07/05/2001 | WO2000073348A3 Methods and compositions for inhibiting neoplastic cell growth |
| 07/05/2001 | WO2000071679A3 Human oxidoreductase proteins |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000069896A3 Molecular interactions in haematopoietic cells |
| 07/05/2001 | WO2000061622A3 Genes associated with diseases of the kidney |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000055621A8 Blood leucocyte apheresis for treatment of disease |
| 07/05/2001 | WO2000034483A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | WO2000003022A9 Expression of herbicide tolerance genes in plant plastids |
| 07/05/2001 | WO1999051625A9 Peptides causing formation of compact structures |
| 07/05/2001 | US20010007155 Producing transgenic potato plant cells and plants synthesizing starch with modified viscosity and phosphate content |
| 07/05/2001 | US20010007152 Obtained by immunizing transgenic mice which produce human leukocyte antigen (HLA) with tumor-associated antigens and recovering the nucleic acids encoding the T cell receptors from the cytotoxic T lymphocytes; diagnosis and therapy |
| 07/05/2001 | US20010007025 Antisense modulation of bcl-x expression |
| 07/05/2001 | US20010007022 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free N-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 07/05/2001 | US20010007020 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/05/2001 | US20010007019 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006949 Methods and compositions for producing cells resistant to apoptosis |
| 07/05/2001 | US20010006939 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 07/05/2001 | US20010006816 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006815 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 07/05/2001 | US20010006814 Chemical modification |
| 07/05/2001 | US20010006813 Cultivation of eucaryotic cells |
| 07/05/2001 | US20010006798 Novel FtsL |
| 07/05/2001 | US20010006797 Transfection cell with genetic vector |
| 07/05/2001 | US20010006796 Nucleic acids encoding variant human vectors |
| 07/05/2001 | US20010006781 Cancer cells capable of tumorigenesis but incapable of infiltration and metastasis, process for preparing the same, and method for screening gene relating to metastasis by using the same |
| 07/05/2001 | US20010006779 Isolated gene coding polypeptide |
| 07/05/2001 | US20010006776 Methods for treatment of hiv and other infections using a t cell or viral activator and anti-retroviral combination therapy |
| 07/05/2001 | US20010006634 Providing a bonding composition comprising isolated chondrocytes mixed with a biological gel, applying composition to a surface of first cartilage piece and contacting surface with second cartilage piece |
| 07/05/2001 | US20010006631 Alloactivated lymphocytes in a pharmaceutical excipient; immunotherapy |
| 07/05/2001 | DE19964113A1 Device for growing skin cells, useful for wound treatment and drug or cosmetic testing, contains membrane bags, removable under sterile conditions, on which cells are grown |
| 07/05/2001 | CA2685457A1 Insecticidal proteins from bacillus thuringiensis |
| 07/05/2001 | CA2406668A1 High affinity tcr proteins and methods |
| 07/05/2001 | CA2396039A1 Gfr.alpha.1-ret specific agonists and methods therefor |
| 07/05/2001 | CA2395957A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 07/05/2001 | CA2395950A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | CA2395535A1 Method for the production of vitamin a |
| 07/05/2001 | CA2395423A1 P. gingivalis antigenic composition |
| 07/05/2001 | CA2395335A1 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | CA2395299A1 Method for producing 6-0-.alpha.-d-glucopyranosyl-d-sorbite |
| 07/05/2001 | CA2395271A1 Cell culture medium containing growth factors and l-glutamine |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395003A1 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | CA2394807A1 Gibberellin 2.beta.-hydroxylase genes of rice and uses thereof |
| 07/05/2001 | CA2394295A1 Antibodies against plasma cells |
| 07/05/2001 | CA2394174A1 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | CA2392703A1 Human heparanase-related polypeptide and nucleic acid |
| 07/04/2001 | EP1113081A1 Implication of a known gene named CP2/LSF/LBP-1 in Alzheimer's disease |
| 07/04/2001 | EP1113072A1 Tissue engineering using mandibular cells |
| 07/04/2001 | EP1112371A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 07/04/2001 | EP1112368A1 Use of protein kinase kiaa0551 as pharmaceutical |
| 07/04/2001 | EP1112365A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 07/04/2001 | EP1112364A2 Stomach polypeptide zsig28 |
| 07/04/2001 | EP1112363A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112360A1 Ecdysone receptors and methods for their use |
| 07/04/2001 | EP1112358A2 Dna sequence encoding oncofetal ferritin protein |
| 07/04/2001 | EP1112354A1 Novel protein kinase molecules and uses therefor |
| 07/04/2001 | EP1112353A2 Recombinant protein production in urine |
| 07/04/2001 | EP1112351A2 Polymerase chimeras |
| 07/04/2001 | EP1112349A2 Propagation and/or derivation of embryonic stem cells |
| 07/04/2001 | EP1112348A2 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 07/04/2001 | EP1112347A1 Methods for generating doubled haploid plants |